Share
   
Title
Code
Session Type
Venue
Date Time
Co-Chairs:
14:30
TUAD0106
Introductory remarks
Marijke Wijnroks, The Global Fund to Fight AIDS, Tuberculosis and Malaria, Switzerland
14:35
TUAD0101
Wide-ranging real-world impacts of a policy change on treatment eligibility on ART initiation and retention in care in Zambia
Aaloke Mody, University of California, United States
Abstract
Slides
14:49
TUAD0102
Pre-ART peak and plateau: early lessons from Zimbabwe on operational impact of "pre-ART mop-up" on ART initiation rates under Treat All
Karen Webb, Organisation for Public Health Interventions and Development, Zimbabwe
Abstract
Slides
15:03
TUAD0103
Evaluating the feasibility of implementing UNAIDS' 90 90 90 strategy, achieving universal access to treatment and eliminating HIV in Malawi
Sally Blower, University of California, United States
Abstract
15:17
TUAD0104
Generic treatments for HIV, HBV, HCV, TB could be mass produced for < $90 per patient
Dzintars Gotham, Independent,
Abstract
Slides
15:31
TUAD0105
Comparative analysis of ARV costs before and after the Clinical Protocol and Therapeutic Guidelines for the management of adult HIV infection (PCDT) was adopted in 2013 in Brazil
Maria Cristina Pimenta, Ministry of Health of Brazil, Brazil
Abstract
15:45
TUAD0106LB
Index partner testing and targeted case finding in northern Haiti
Valerie Alice Francois, Jhpiego, Haiti
Abstract
Slides